Abstract
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) infections with multi-drug resistance needs effective and alternative control strategies. In this study we investigated the adjuvant effect of a novel furan fatty acid, 7,10-epoxyoctadeca-7,9-dienoic acid (7,10-EODA) against multidrug-resistant S. aureus (MDRSA) strain 01ST001 by disc diffusion, checker board and time kill assays. Further the membrane targeting action of 7,10-EODA was investigated by spectroscopic and confocal microscopic studies. 7,10-EODA exerted synergistic activity along with β-lactam antibiotics against all clinical MRSA strains, with a mean fractional inhibitory concentration index below 0.5. In time-kill kinetic study, combination of 7,10-EODA with oxacillin, ampicillin, and penicillin resulted in 3.8–4.2 log10 reduction in the viable counts of MDRSA 01ST001. Further, 7,10-EODA dose dependently altered the membrane integrity (p < 0.001) and increased the binding of fluorescent analog of penicillin, Bocillin-FL to the MDRSA cells. The membrane action of 7,10-EODA further facilitated the uptake of several other antibiotics in MDRSA. The results of the present study suggested that 7,10-EODA could be a novel antibiotic adjuvant, especially useful in repurposing β-lactam antibiotics against multidrug-resistant MRSA.
Similar content being viewed by others
References
Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzie T, Peters G (2012) New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents 39:96–104. doi:10.1016/j.ijantimicag.2011.09.028
David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687. doi:10.1128/CMR.00081-09
Grundmann H, Aires-de-sousa M, Boyce J, Tiemersma E (2006) Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874–885. doi:10.1016/S0140-6736(06)68853-3
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771. doi:10.1001/jama.298.15.1763
Brown D (2015) Antibiotic resistance breakers can repurpose drugs to fill the antibiotic discovery void. Nat Rev Drug Discov 14:821–832. doi:10.1038/nrd4675
Friedman M (2015) Antibiotic-resistant bacteria: prevalence in food and inactivation by food compatible compounds and plant extracts. J Agric Food Chem 63:3805–3822. doi:10.1021/acs.jafc.5b00778
Desbios AP, Smith VJ (2010) Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 85:1629–1642. doi:10.1007/s00253-009-2355-3
Speiteller G (2005) Furan fatty acids: occurrence, synthesis, and reactions. Are furan fatty acids responsible for cardioprotective effect of fish diet? Lipids 40:755–771. doi:10.1007/s11745-005-1438-5
Ishii K, Okajima H, Okada Y, Watanabe H (1989) Effects of phosphatidylcholines containing furan fatty acid on oxidation in multi lamellar liposomes. Chem Pharm Bull 37:1396–1398. doi:10.1248/cpb.37.1396
Teixeira A, Cox RC, Egmond MR (2013) Furan fatty acids efficiently rescue brain cells from cell death induced by oxidative stress. Food Funct 4:1209–1215. doi:10.1039/c3fo60094g
Wakimoto T, Kondo H, Nii H, Kimura K, Egami Y, Oka Y, Yoshida M, Kida E, Ye Y, Akahoshi S, Asakawa T, Matsumura K, Ishida H, Nukaya H, Tsuji K, Kan T, Abe I (2011) Furan fatty acid as an anti-inflammatory component from the green lipped mussel Perna canaliculus. Proc Natl Acad Sci 108:17533–17537. doi:10.1073/pnas.1110577108
Knechtle P, Diefenbacher M, Greve KB, Brianza F, Folly C, Heider H, Lone MA, Long L, Meyer JP, Roussel P, Ghannoum MA, Schneiter R, Sorensen AS (2014) The natural diyene-furan fatty acid EV-086 is an inhibitor of fungal delta-9 fatty acid desaturation with efficacy in a model of skin detmatophytosis. Antimicrob Agents Chemother 58:1455–1466. doi:10.1128/AAC.01443-13
Ellamar JB, Song KS, Kim HR (2011) One-step production of a biologically active novel furan fatty acid from 7,10-dihydroxy-8(E)-octadecenoic acid. J Agric Food Chem 59:8175–8179. doi:10.1021/jf2015683
Dasagrandhi C, Ellamar JB, Kim YS, Kim HR (2016) Antimicrobial activity of a novel furan fatty acid, 7,10-epoxyoctadeca-7,9-dienoic acid against methicillin-resistant Staphylococcus aureus. Food Sci Biotechnol 25:1671–1675. doi:10.1007/s10068-016-0257-6
Clinical and Laboratory and Standards Institute (2015) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards. CLSI document M07-A10, 10th edn. Clinical and Laboratory and Standards Institute, Pennsylvania
Nair DR, Monteiro JM, Memmi G, Thanassi J, Pucci M, Schwartzman J, Pinho MG, Cheung AL (2015) Characterization of a novel small molecule that potentiates β-lactam activity against Gram-positive and Gram-negative pathogens. Antimicrob Agents Chemother 59:1876–1885. doi:10.1128/AAC.04164-14
Cabral V, Luo X, Junqueira E, Costa SS, Mulhovo S, Duarte A, Couto I, Viveiros M, Ferreira MJ (2015) Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives. Phytomedicine 25:769–772. doi:10.1016/j.phymed.2015.02.003
Cottagnoud P, Cottagnoud M, Tauber MG (2003) Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrob Agents Chemother 47:144–147. doi:10.1128/AAC.47.1.144-147.2003
Parsons JB, Yao J, Frank MW, Jackson P, Rock CO (2012) Membrane disruption by antimicrobial fatty acids releases low molecular weight proteins from Staphylococcus aureus. J Bacteriol 194:5294–5530. doi:10.1128/JB.00743-12
Bernal P, Lemaire S, Pinho MG, Mobashery S, Hinds J, Taylor PW (2010) Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupt penicillin-binding protein (PBP) 2a mediated β-lactam resistance by delocalizing PBP2. J Biol Chem 285:24055–24065. doi:10.1074/jbc.M110.114793
Marks LR, Clement EA, Hakansson AP (2013) Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET. PLoS ONE 8:e63158. doi:10.1371/journal.pone.0063158
Hess DI, Stanley MJH, Wells CL (2014) Antibacterial synergy of glycerol monolaurate and aminoglycosides in S. aureus biofilms. Antimicrob Agents Chemother 58:6970–6973. doi:10.1128/AAC.03672-14
Gilbertson JR, Langkamp HH, Connamacher R, Platt D (1984) Use of lipids to potentiate the antibacterial activity of aminoglycosides. Antimicrob Agents Chemother 26:306–309
Kang R, Kang OH, Seo YS, Mun SH, Zhou T, Shin DW, Kwon DY (2016) The inhibition effect of chlorpromazine against the β-lactam resistance of MRSA. Asian Pac J Trop Dis 9:542–546. doi:10.1016/j.apjtm.2016.04.008
Kalia VC, Wood TK, Kumar P (2014) Evolution of resistance to quorum sensing inhibitors. Microb Ecol 68:13–23. doi:10.1007/s00248-013-0316-y
Chan BC, Han XQ, Lui SL, Wong CW, Wang TB, Cheung DW, Cheng SW, Ip M, Han SQ, Yang XS, Jolivalt C, Lau CB, Leung PC, Fung KP (2014) Combating against methicillin-resistant Staphylococcus aureus-two fatty acids from Purslane (Portulaca oleracear L) exhibit synergistic effect with erythromycin. J Pharm Pharmacol 67:107–116. doi:10.1111/jphp.12315
Acknowledgements
This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and future planning (2015R1A2A2A01005656).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dasagrandhi, C., Kim, YS., Kim, IH. et al. 7,10-Epoxyoctadeca-7,9-dienoic Acid: A Small Molecule Adjuvant That Potentiates β-Lactam Antibiotics Against Multidrug-Resistant Staphylococcus aureus . Indian J Microbiol 57, 461–469 (2017). https://doi.org/10.1007/s12088-017-0680-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-017-0680-2